Alise Pharma Expands International Distribution to 15 Markets
Since our founding, Alise Pharma has been committed to making pharmaceutical-grade supplements accessible to anyone who values evidence-based health products. Today, we are taking a major step toward that vision by officially expanding our direct-to-consumer platform to 15 international markets. Customers in the United Kingdom, Germany, France, the Netherlands, Sweden, Denmark, Norway, Australia, New Zealand, Japan, South Korea, Singapore, the United Arab Emirates, Canada, and Mexico can now order directly from our website with localized pricing, shipping, and customer support.
This expansion has been one of our most requested initiatives. Over the past two years, we have received thousands of inquiries from international customers who either relied on forwarding services or traveled to the US to stock up on our products. That experience was far from ideal, and we are glad to finally offer a seamless purchasing experience to these markets.
Building the Logistics Infrastructure
Shipping supplements internationally is more complex than it might appear. Each country has its own regulatory requirements for dietary supplements, including labeling standards, permitted ingredient lists, maximum dosage thresholds, and import documentation. A product that is perfectly compliant in the United States may require modified labeling or reformulation for sale in the EU, Japan, or Australia.
To manage this complexity, we have established three regional fulfillment hubs: one in the Netherlands serving European markets, one in Singapore serving the Asia-Pacific region, and one in Toronto serving Canada and Mexico. Each hub maintains inventory of our full product line, pre-labeled for its respective markets and stored under our standard temperature-controlled conditions. This distributed model allows us to offer delivery times of 3 to 7 business days in most markets — comparable to what our US customers experience.
We partnered with a global logistics firm that specializes in health and pharmaceutical products, ensuring that every shipment meets cold-chain requirements where applicable and complies with customs regulations. Every package is tracked end-to-end, and our customer support team can provide real-time shipping updates in local time zones.
Maintaining Quality Across Borders
One of the questions we receive most frequently is whether our international products are the same quality as those sold in the US. The answer is an unequivocal yes. Every product we sell globally is manufactured at the same GMP-certified facilities in the United States, using the same raw materials, formulations, and quality control processes. The only differences are in packaging and labeling, which are adapted to meet local regulatory requirements.
Our third-party testing program applies equally to international inventory. Every batch is tested for purity, potency, and contaminants by an ISO 17025 accredited laboratory, and Certificates of Analysis are available for every product regardless of where it is purchased. We have also engaged local regulatory consultants in each market to ensure ongoing compliance as regulations evolve.
For our European customers specifically, all products comply with EU food supplement regulations, including the EU Food Information Regulation for labeling and the maximum levels set by individual member states. Our Japanese products carry the required nutritional function claim labels, and our Australian products are listed on the Australian Register of Therapeutic Goods where required.
Localized Customer Experience
International expansion is not just about shipping — it is about creating a customer experience that feels native to each market. Our website now supports localized pricing in 10 currencies (USD, EUR, GBP, CAD, AUD, NZD, JPY, KRW, SGD, and AED), with prices inclusive of local taxes and duties. Customers will not encounter surprise charges at checkout or upon delivery.
We have also expanded our customer support team to provide assistance in English, German, French, Japanese, and Korean during local business hours. Support is available via email, live chat, and phone, with the same response-time commitments our US customers receive. Our knowledge base and FAQ sections have been translated for each market, and product pages include market-specific regulatory disclaimers and recommended usage information.
What Comes Next
This initial expansion to 15 markets is just the beginning. We are actively evaluating additional markets in Southeast Asia, South America, and the Middle East for 2026 launches. Our priority is ensuring that every market we enter receives the same standard of product quality, customer service, and regulatory compliance that has defined the Alise Pharma experience in the United States.
We are also exploring partnerships with select retail pharmacies and health-focused retailers in key international markets. While our direct-to-consumer model will remain our primary channel, we recognize that some customers prefer to purchase supplements in person, and we want to meet them where they are. Any retail partnerships will be carefully vetted to ensure proper storage conditions and customer education.
To our international customers who have been waiting for this day: thank you for your patience, and welcome to Alise Pharma. We are thrilled to finally serve you directly.
Key Takeaways
- ✓Alise Pharma now ships directly to 15 international markets across Europe, Asia-Pacific, the Middle East, and the Americas.
- ✓Three regional fulfillment hubs (Netherlands, Singapore, Toronto) enable 3-7 business day delivery with full cold-chain compliance.
- ✓All international products are manufactured at the same US GMP-certified facilities with identical quality control and third-party testing.
- ✓Localized pricing in 10 currencies, multilingual customer support, and market-specific regulatory compliance are all included.
- ✓Additional markets in Southeast Asia, South America, and the Middle East are under evaluation for 2026 expansion.
Amanda Torres oversees global operations at Alise Pharma, including supply chain management, fulfillment logistics, and international regulatory compliance. With an MBA from Wharton and 12 years of experience scaling direct-to-consumer health brands, Amanda has been instrumental in building the operational infrastructure that supports Alise Pharma's rapid growth. She is focused on delivering a world-class customer experience in every market the company serves.